The overall aim of the Biocarrier – Biomaterials for Multistage Drug and Cell Delivery group is to develop molecularly-designed, cell-instructive biomaterials as 3D artificial matrices for the delivery of drugs, biomolecules, genes and cells with implications in tissue regeneration and cancer diagnosis and treatment.